341 filings
Page 4 of 18
6-K
j6dafvmqkflo6
3 Mar 22
Report of Foreign Private Issuer
7:41am
6-K
hk44rs48q60l6gopnob
2 Mar 22
Report of Foreign Private Issuer
7:01am
6-K
qx9baha 9z4
16 Dec 21
Report of Foreign Private Issuer
8:06am
6-K
8hyx4e 3z9hoxdm8kr
22 Nov 21
Report of Foreign Private Issuer
7:06am
6-K
in6au
22 Nov 21
Report of Foreign Private Issuer
7:02am
6-K
k20b5df
8 Nov 21
Report of Foreign Private Issuer
7:10am
6-K
10sjk2zq5xd kiyt6ds
4 Nov 21
Report of Foreign Private Issuer
8:01am
6-K
7ofg7f1p4y nnm
11 Aug 21
Kamada Reports Second Quarter and First Half 2021 Financial Results, Recent Achievements and Corporate Development Activities
7:02am
6-K
vl9y6i8ax
5 Aug 21
Report of Foreign Private Issuer
8:12am
6-K
fenhwr7
2 Jun 21
Kedrion and Kamada Announce FDA Approval of KEDRAB® Label Update, Confirming Safety and Effectiveness in Children
7:08am
6-K
5pc5vmjsmabok41ecqx
12 May 21
Kamada Reports First Quarter 2021 Financial Results, Recent Achievements and Corporate Development Activities
7:06am
6-K
a6epug jb
5 May 21
Report of Foreign Private Issuer
7:16am
6-K
zow5d
7 Apr 21
Kamada Announces Amendment to GLASSIA® License Agreement with Takeda
7:01am
6-K
932fro8wkq7jsq
31 Mar 21
Report of Foreign Private Issuer
6:01am
6-K
hc126tks0 ink
9 Mar 21
Kamada to Present at the Jefferies Global Plasma Summit
7:00am
6-K
j3ql1kd
3 Mar 21
Transaction Furthers Kamada’s Strategic Objective to Evolve into a Fully Integrated Specialty Plasma Company
7:00am
6-K
8vrs7q68l9fij
24 Feb 21
Report of Foreign Private Issuer
7:01am
6-K
qx54r6khw9h a637m3
10 Feb 21
Kamada Reports Fourth Quarter and Fiscal Year 2020 Financial Results, Recent Achievements and Corporate Development Activities
7:00am
6-K
zaa8dl8qv1ix12wyv
3 Feb 21
Report of Foreign Private Issuer
7:03am